Leon-nanodrugs GmbH | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Leon-nanodrugs GmbH

BRIEF

published on 08/06/2024 at 10:05, 3 months 15 days ago

Leon-nanodrugs Secures Series D Financing for Nanoencapsulation Production Systems

GMP Manufacturing Cell & Gene Therapy Series D Financing Nanoencapsulation LEON
PRESS RELEASE

published on 08/06/2024 at 10:00, 3 months 15 days ago

leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation
leon-nanodrugs secures funds in a series D financing round to expand nanoencapsulation portfolio for genetic material & active substances, aiming for efficient GMP manufacturing

Biopharma Industry LEON-nanodrugs GMP Manufacturing Series D Financing Nanoencapsulation
BRIEF

published on 04/11/2024 at 13:05, 7 months 9 days ago

LEON-nanodrugs GmbH Advances Nanoparticle Drug Delivery Manufacturing with CMAC Collaboration

Drug Delivery Leon-nanodrugs GmbH Nanoparticle Technology CMAC Collaboration Pharmaceutical Manufacturing
PRESS RELEASE

published on 04/11/2024 at 13:00, 7 months 9 days ago

Technical Evaluation by CMAC Introduces LEON’s Cutting-Edge Formulation Technology
Technical Evaluation by CMAC introduces LEON's cutting-edge formulation technology, revolutionizing lipid nanoparticle production for drug delivery. Joint effort with experts proves success in in-vitro and in-vivo tests

Drug Delivery Pharmaceutical Manufacturing LEON-nanodrugs CMAC Lipid Nanoparticles
PRESS RELEASE

published on 07/18/2023 at 09:00, 1 year 4 months ago

leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
PRESS RELEASE

published on 05/16/2023 at 10:00, 1 year 6 months ago

leon-nanodrugs GmbH: LEON appoints Dr. Setu Kasera as Chief Scientific Officer
PRESS RELEASE

published on 04/27/2023 at 14:00, 1 year 6 months ago

LEON sets up lab facilities at the Innovation and Start-Up Center for Biotechnology (IZB) in Munich
PRESS RELEASE

published on 01/03/2023 at 15:00, 1 year 10 months ago

LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles

Accesswire

Published on 11/21/2024 at 10:03, 54 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 57 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 57 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 22 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 32 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 27 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 52 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 59 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 37 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE